February 24, 2022 Comments Off on New patent for Nexus Pharms drug EMERPHED Posted in: Patent Added Annual Drug Patent Expirations for EMERPHED Emerphed is a drug marketed by Nexus Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Nexus Pharms drug EMERPHED appeared first on DrugPatentW…
February 24, 2022 Comments Off on New tentative approval for Zydus Pharms drug roflumilast Posted in: Tentative Approval Roflumilast is the generic ingredient in two branded drugs marketed by Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, Mylan, Strides Pharma, and Torrent and, and is included in seven…
The post New tentative approval for Zydus Pharms drug r…
